Defective generation of alloreactive cytotoxic T lymphocytes (CTL) in human monoclonal gammopathies
- PMID: 3263229
- PMCID: PMC1541589
Defective generation of alloreactive cytotoxic T lymphocytes (CTL) in human monoclonal gammopathies
Abstract
The generation of cytotoxic T lymphocytes (CTL) towards allogeneic cells was investigated in 19 patients with monoclonal gammopathy of undetermined significance (MGUS) and 31 patients with multiple myeloma (MM). This function was significantly decreased in all patients. The cytotoxic deficiency was more pronounced in MM with poor prognosis than MM with good prognosis and MGUS patients. A phenotypic analysis of PBT lymphocytes showed that poor prognosis MM also had the highest proportions of activated cells (HLA-DR+) in CD8+ subpopulations. CTL were generated after depletion of CD11+ lymphocytes (including suppressor cells) or after inhibition of suppressor function with deoxyguanosine. No increase of cytotoxicity was detected under these conditions. Exogenous supplementation of recombinant interleukin 2 (rIL-2) was also ineffective. These data indicate that MG PBT lymphocytes are unable to fully differentiate into CTL following allogeneic stimulation. This deficiency is most evident in MM patients already showing the poorest prognosis and the most altered T cell phenotype.
Similar articles
-
Defective interleukin-2 induction of lymphokine-activated killer (LAK) activity in peripheral blood T lymphocytes of patients with monoclonal gammopathies.Clin Exp Immunol. 1990 Jan;79(1):100-4. doi: 10.1111/j.1365-2249.1990.tb05134.x. Clin Exp Immunol. 1990. PMID: 2105868 Free PMC article.
-
Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire.Cancer. 2006 Mar 15;106(6):1296-305. doi: 10.1002/cncr.21746. Cancer. 2006. PMID: 16475149
-
Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.Hum Immunol. 2004 Feb;65(2):142-56. doi: 10.1016/j.humimm.2003.12.001. Hum Immunol. 2004. PMID: 14969769
-
Pathogenetic relation between monoclonal gammopathies of undetermined significance and multiple myeloma.Stem Cells. 1995 Aug;13 Suppl 2:10-21. Stem Cells. 1995. PMID: 8520496 Review.
-
Immunophenotypic and DNA content characteristics of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance.Pathol Biol (Paris). 1999 Feb;47(2):119-27. Pathol Biol (Paris). 1999. PMID: 10192879 Review.
Cited by
-
Immune checkpoint blockade for hematologic malignancies: a review.Stem Cell Investig. 2017 Apr 19;4:32. doi: 10.21037/sci.2017.03.04. eCollection 2017. Stem Cell Investig. 2017. PMID: 28529947 Free PMC article. Review.
-
Defective interleukin-2 induction of lymphokine-activated killer (LAK) activity in peripheral blood T lymphocytes of patients with monoclonal gammopathies.Clin Exp Immunol. 1990 Jan;79(1):100-4. doi: 10.1111/j.1365-2249.1990.tb05134.x. Clin Exp Immunol. 1990. PMID: 2105868 Free PMC article.
-
Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myeloma.Cancer Immunol Immunother. 2011 Jul;60(7):985-97. doi: 10.1007/s00262-011-1009-3. Epub 2011 Apr 3. Cancer Immunol Immunother. 2011. PMID: 21461886 Free PMC article.
-
Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma.Int J Mol Sci. 2019 Jun 10;20(11):2822. doi: 10.3390/ijms20112822. Int J Mol Sci. 2019. PMID: 31185596 Free PMC article. Review.
-
Lymphocyte recovery and clinical response in multiple myeloma patients receiving interferon alpha 2 beta after intensive therapy.Br J Cancer. 1996 Jan;73(2):236-40. doi: 10.1038/bjc.1996.41. Br J Cancer. 1996. PMID: 8546912 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials